✦ LIBER ✦

Gene transfer of endostatin enhances the efficacy of doxorubicin to suppress human hepatocellular carcinomas in mice

✍ Scribed by Fengjun Liu; Gang Tan; Jie Li; Xuesong Dong; Geoffrey W. Krissansen; Xueying Sun

Book ID: 108583951
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 254 KB
Volume: 98
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2007.00542.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Endostatin gene therapy enhances the eff

Endostatin gene therapy enhances the efficacy of paclitaxel to suppress breast cancers and metastases in mice

✍ Jie Li; Xuesong Dong; Zongzhen Xu; Xian Jiang; Hongchi Jiang; Geoffrey W Krissan 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 383 KB

Endostatin gene therapy enhances the eff

Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice

✍ Flávia Gomes de Góes Rocha; Karen Cristina Barbosa Chaves; Roger Chammas; Jean P 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 654 KB

Antisense hypoxia-inducible factor 1α ge

Antisense hypoxia-inducible factor 1α gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma

✍ Fengjun Liu; Peijun Wang; Xian Jiang; Gang Tan; Haiquan Qiao; Hongchi Jiang; Geo 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Liposome-mediated gene transfer of K1-5

Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice

✍ Takuji Torimura; Takato Ueno; Michio Sata 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 433 KB

Tissue-specific growth suppression and c

Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene

✍ G W Xu; Z T Sun; K Forrester; X W Wang; J Coursen; C C Harris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 646 KB

HCC patients are generally resistant to chemotherapy, Selective expression of cytotoxic gene products in tuwhich, in some cases, may be the result of a loss of function mor cells is one of the goals of gene therapy for treating mutation in the p53 gene. cancer. We are developing such a strategy for

Tissue-specific growth suppression and c

Tissue-specific growth suppression and chemosensitivity promotion in human hepatocellular carcinoma cells by retroviral-mediated transfer of the wild-type p53 gene

✍ GW Xu; ZT Sun; K Forrester; XW Wang; J Coursen; CC Harris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB